YMAIF yields 3571.43% · JNJ yields 2.13%● Live data
📍 YMAIF pulled ahead of the other in Year 1
Combined, YMAIF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of YMAIF + JNJ for your $10,000?
Yoma Strategic Holdings Ltd., an investment holding company, engages in the real estate, automotive and heavy equipment, consumer, financial, and investment businesses in Singapore, Myanmar, and the People's Republic of China. The company's Real Estate Development segment develops and sells land and properties. Its Real Estate Services segment provides project management, design, and estate management services, as well as property leasing services and operates golf estate. The company's Automotive & Heavy Equipment segment supplies and sells agriculture and construction equipment, passenger and commercial vehicles, and related parts, as well as offers maintenance services. Its Consumer segment engages in the operation of restaurants; bottling and distribution of beverages; food wholesale business; and provision of logistics services. The company's Financial Services segment provides vehicle financing; and invests in mobile financial services. Its Investments segment invests in the infrastructure, tourism, power agricultural, and other sectors, as well as leases investment properties. The company also engages in leasing automotive equipment. The company was formerly known as Sea View Hotel Limited. Yoma Strategic Holdings Ltd. was incorporated in 1962 and is based in Singapore.
Full YMAIF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.